The healthy ageing segment is now big business with demand for nutrition and food products for the elderly population at an all-time high.
At the other end of the scale, younger people are increasingly aware that the nutrition and health choices they make today will affect their quality of life in older age.
The webinar aims to explore the opportunities for innovation in this space, where top researchers and business leaders contribute in identifying the main risk factors for ageing.
This year’s line-up will also delve into the role nutrition and supplements can play to slow down ageing and maintain health as the population gets older.
Webinar line-up
The webinar kicks off with the founder of Prime Fifty, Max Gowland, discussing malnutrition in older adults and the food and supplemental approaches to ward off nutritional gaps.
DuPont Nutrition & Biosciences’ global segment lead for food and beverage, Mark Rhode then takes over with a presentation entitled ‘Ingredients for Healthy Aging,’ where topics up for discussion include the benefits of probiotics, protein and human milk oligosaccharides for the ageing process.
Atlantia Food Clinical Trials take charge of the next session with the company’s chief commercial officer Barry Skillington and senior project manager Emily Goodbody reviewing the wealth of clinical studies in elderly populations.
Here, the presenting team discuss the challenges and considerations when designing and conducting clinical trials involving elderly participants.
Finally, director of scientific and regulatory affairs at Food Supplements Europe Patrick Coppens and founder and senior consultant at Healthy Marketing Team Peter Wennström take part in a panel discussion entitled ‘Senior consumer needs – gearing products and marketing for the ‘young at heart.’
This NutraIngredients webinar will take place on 20 November 2019 at 12:00pm GMT. For more information and to register for FREE, please click HERE.
The Healthy Ageing webinar is sponsored by:
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries.
The company use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations.
Atlantia Food Clinical Trials is a company in delivering clinical studies: performing acute, observational and intervention studies to ICH GCP standards for the functional foods and beverages, supplements, pre- and probiotics, medical foods, infant formula and microbiome-based therapeutics sector.
After having spun out of the APC Microbiome Institute, the company have developed a unique business model that combines ties with the academic community, operating as an independent contract research organisation (CRO) where the Intellectual Property belongs to the sponsor.
The company provides end-to-end clinical trial solutions, from design to health claim, with the capabilities to manage all trial aspects.
Some of its extensive clinical expertise areas are healthy ageing, gastrointestinal, physical activity and sports, nutritional, stress and cognitive, cardiovascular, metabolic, bone and joints, immune, women, skin and microbiome health.